Information about Temasek’s involvement in cross-border screening of travellers

Messages being circulated about a cross-border initiative to screen travellers between Singapore and Malaysia for COVID-19 are not correct.

Temasek has not been appointed by the Singapore Government to handle all COVID-19 screening for travellers entering and exiting the country. Temasek Foundation continues to support various efforts to combat the spread of COVID-19 infections.

Affinidi, a company founded by Temasek, has partnered BP Healthcare Group, a swab operator in Malaysia, to issue cryptographically verifiable COVID-19 swab test results. For more details, you may refer to Affinidi’s statement on their website.

Subscribe to our newsletter

Stay up to date with our latest news, insights and stories

Select a type of content
    Please select Stories you are interested in.
    Please give us your consent.
    Please confirm that you are not a robot.